The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Saad Mark E since year 2005.
The trader's CIK number is 1295913.
At the time of the last reporting, Saad Mark E was the Officer of Axsome Therapeutics, Inc. .
(stock ticker symbol AXSM).
See this page for all insider trading activities at Axsome Therapeutics, Inc. .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2019-05-23 | AXSM | Axsome Therapeutics, Inc. | Buy | 3,500 | 22.33 | 78,155 |
| 2012-03-14 | CYTX | Cytori Therapeutics, Inc. | Buy | 10,000 | 2.54 | 25,450 |
| 2011-08-12 | CYTX | Cytori Therapeutics, Inc. | Buy | 6,500 | 3.12 | 20,299 |
| 2010-05-21 | CYTX | Cytori Therapeutics, Inc. | Buy | 6,000 | 4.29 | 25,740 |
| 2008-08-12 | CYTX | Cytori Therapeutics, Inc. | Buy | 15,000 | 6.69 | 100,305 |
| 2006-09-05 | CYTX | Cytori Therapeutics, Inc. | Buy | 1,850 | 5.08 | 9,396 |
| 2006-09-01 | CYTX | Cytori Therapeutics, Inc. | Buy | 1,550 | 5.31 | 8,224 |
| 2006-08-31 | CYTX | Cytori Therapeutics, Inc. | Buy | 750 | 5.47 | 4,106 |
| 2006-08-29 | CYTX | Cytori Therapeutics, Inc. | Buy | 800 | 5.22 | 4,176 |
| 2006-08-30 | CYTX | Cytori Therapeutics, Inc. | Buy | 750 | 5.42 | 4,067 |
| 2006-08-25 | CYTX | Cytori Therapeutics, Inc. | Buy | 800 | 4.99 | 3,993 |
| 2006-08-28 | CYTX | Cytori Therapeutics, Inc. | Buy | 800 | 5.20 | 4,157 |
| 2006-08-23 | CYTX | Cytori Therapeutics, Inc. | Buy | 850 | 4.28 | 3,637 |
| 2006-08-24 | CYTX | Cytori Therapeutics, Inc. | Buy | 850 | 4.62 | 3,928 |
| 2006-08-21 | CYTX | Cytori Therapeutics, Inc. | Buy | 883 | 4.52 | 3,991 |
| 2006-08-22 | CYTX | Cytori Therapeutics, Inc. | Buy | 1,617 | 4.27 | 6,907 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Saad Mark E (Officer of Axsome Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.